Carotid  ||| S:0 E:8 ||| JJ
endarterectomy  ||| S:8 E:23 ||| NN
and  ||| S:23 E:27 ||| CC
treatment  ||| S:27 E:37 ||| NN
options  ||| S:37 E:45 ||| NNS
for  ||| S:45 E:49 ||| IN
carotid  ||| S:49 E:57 ||| FW
occlusive  ||| S:57 E:67 ||| FW
disease  ||| S:67 E:75 ||| FW
Atherosclerotic  ||| S:75 E:91 ||| FW
stenosis  ||| S:91 E:100 ||| FW
of  ||| S:100 E:103 ||| IN
the  ||| S:103 E:107 ||| DT
extracranial  ||| S:107 E:120 ||| JJ
internal  ||| S:120 E:129 ||| JJ
carotid  ||| S:129 E:137 ||| JJ
artery  ||| S:137 E:144 ||| NN
accounts  ||| S:144 E:153 ||| NNS
for  ||| S:153 E:157 ||| IN
15 ||| S:157 E:159 ||| CD
% ||| S:159 E:160 ||| NN
-20 ||| S:160 E:163 ||| CD
%  ||| S:163 E:165 ||| NN
of  ||| S:165 E:168 ||| IN
ischemic  ||| S:168 E:177 ||| JJ
strokes ||| S:177 E:184 ||| NNS
,  ||| S:184 E:186 ||| ,
depending  ||| S:186 E:196 ||| VBG
on  ||| S:196 E:199 ||| IN
the  ||| S:199 E:203 ||| DT
population  ||| S:203 E:214 ||| NN
studied ||| S:214 E:221 ||| VBD
.  ||| S:221 E:223 ||| .
Carotid  ||| S:223 E:231 ||| JJ
endarterectomy  ||| S:231 E:246 ||| NNS
( ||| S:246 E:247 ||| -LRB-
CEA ||| S:247 E:250 ||| NNP
)  ||| S:250 E:252 ||| -RRB-
is  ||| S:252 E:255 ||| VBZ
the  ||| S:255 E:259 ||| DT
most  ||| S:259 E:264 ||| RBS
frequently  ||| S:264 E:275 ||| RB
performed  ||| S:275 E:285 ||| VBN
operation  ||| S:285 E:295 ||| NN
to  ||| S:295 E:298 ||| TO
prevent  ||| S:298 E:306 ||| VB
stroke ||| S:306 E:312 ||| NN
.  ||| S:312 E:314 ||| .
Since  ||| S:314 E:320 ||| IN
the  ||| S:320 E:324 ||| DT
1990s ||| S:324 E:329 ||| NNS
,  ||| S:329 E:331 ||| ,
several  ||| S:331 E:339 ||| JJ
randomized  ||| S:339 E:350 ||| NNS
controlled  ||| S:350 E:361 ||| VBN
trials  ||| S:361 E:368 ||| NNS
have  ||| S:368 E:373 ||| VBP
been  ||| S:373 E:378 ||| VBN
completed  ||| S:378 E:388 ||| VBN
in  ||| S:388 E:391 ||| IN
which  ||| S:391 E:397 ||| WDT
the  ||| S:397 E:401 ||| DT
authors  ||| S:401 E:409 ||| NNS
analyzed  ||| S:409 E:418 ||| VBD
the  ||| S:418 E:422 ||| DT
risks  ||| S:422 E:428 ||| NNS
and  ||| S:428 E:432 ||| CC
benefits  ||| S:432 E:441 ||| NNS
of  ||| S:441 E:444 ||| IN
the  ||| S:444 E:448 ||| DT
procedure  ||| S:448 E:458 ||| NN
for  ||| S:458 E:462 ||| IN
patients  ||| S:462 E:471 ||| NNS
with  ||| S:471 E:476 ||| IN
symptomatic  ||| S:476 E:488 ||| NN
and  ||| S:488 E:492 ||| CC
asymptomatic  ||| S:492 E:505 ||| JJ
stenosis  ||| S:505 E:514 ||| NN
of  ||| S:514 E:517 ||| IN
the  ||| S:517 E:521 ||| DT
internal  ||| S:521 E:530 ||| JJ
carotid  ||| S:530 E:538 ||| JJ
artery ||| S:538 E:544 ||| NN
.  ||| S:544 E:546 ||| .
Traditionally ||| S:546 E:559 ||| RB
,  ||| S:559 E:561 ||| ,
CEA  ||| S:561 E:565 ||| NNP
was  ||| S:565 E:569 ||| VBD
compared  ||| S:569 E:578 ||| VBN
with  ||| S:578 E:583 ||| IN
maximal  ||| S:583 E:591 ||| JJ
medical  ||| S:591 E:599 ||| JJ
therapy  ||| S:599 E:607 ||| NN
in  ||| S:607 E:610 ||| IN
its  ||| S:610 E:614 ||| PRP$
efficacy  ||| S:614 E:623 ||| NN
to  ||| S:623 E:626 ||| TO
prevent  ||| S:626 E:634 ||| VB
stroke  ||| S:634 E:641 ||| NN
and  ||| S:641 E:645 ||| CC
death ||| S:645 E:650 ||| NN
;  ||| S:650 E:652 ||| :
however ||| S:652 E:659 ||| RB
,  ||| S:659 E:661 ||| ,
improvements  ||| S:661 E:674 ||| NNS
in  ||| S:674 E:677 ||| IN
endovascular  ||| S:677 E:690 ||| JJ
techniques  ||| S:690 E:701 ||| NNS
have  ||| S:701 E:706 ||| VBP
led  ||| S:706 E:710 ||| VBN
to  ||| S:710 E:713 ||| TO
large  ||| S:713 E:719 ||| JJ
studies  ||| S:719 E:727 ||| NNS
in  ||| S:727 E:730 ||| IN
which  ||| S:730 E:736 ||| WDT
the  ||| S:736 E:740 ||| DT
authors  ||| S:740 E:748 ||| NNS
compared  ||| S:748 E:757 ||| VBN
CEA  ||| S:757 E:761 ||| NNP
with  ||| S:761 E:766 ||| IN
carotid  ||| S:766 E:774 ||| JJ
angioplasty  ||| S:774 E:786 ||| NN
and  ||| S:786 E:790 ||| CC
stenting ||| S:790 E:798 ||| NN
.  ||| S:798 E:800 ||| .
In  ||| S:800 E:803 ||| IN
this  ||| S:803 E:808 ||| DT
review ||| S:808 E:814 ||| NN
,  ||| S:814 E:816 ||| ,
we  ||| S:816 E:819 ||| PRP
will  ||| S:819 E:824 ||| MD
discuss  ||| S:824 E:832 ||| VB
our  ||| S:832 E:836 ||| PRP$
current  ||| S:836 E:844 ||| JJ
knowledge  ||| S:844 E:854 ||| NN
of  ||| S:854 E:857 ||| IN
the  ||| S:857 E:861 ||| DT
role  ||| S:861 E:866 ||| NN
of  ||| S:866 E:869 ||| IN
CEA  ||| S:869 E:873 ||| NNP
in  ||| S:873 E:876 ||| IN
the  ||| S:876 E:880 ||| DT
prevention  ||| S:880 E:891 ||| NN
of  ||| S:891 E:894 ||| IN
stroke  ||| S:894 E:901 ||| NN
in  ||| S:901 E:904 ||| IN
symptomatic  ||| S:904 E:916 ||| NN
and  ||| S:916 E:920 ||| CC
asymptomatic  ||| S:920 E:933 ||| JJ
patients  ||| S:933 E:942 ||| NNS
with  ||| S:942 E:947 ||| IN
carotid  ||| S:947 E:955 ||| JJ
stenosis  ||| S:955 E:964 ||| NN
and  ||| S:964 E:968 ||| CC
compare  ||| S:968 E:976 ||| VB
its  ||| S:976 E:980 ||| PRP$
use  ||| S:980 E:984 ||| NN
to  ||| S:984 E:987 ||| TO
medical  ||| S:987 E:995 ||| JJ
therapy  ||| S:995 E:1003 ||| NN
and  ||| S:1003 E:1007 ||| CC
carotid  ||| S:1007 E:1015 ||| JJ
angioplasty  ||| S:1015 E:1027 ||| NN
and  ||| S:1027 E:1031 ||| CC
stenting ||| S:1031 E:1039 ||| NN
.  ||| S:1039 E:1041 ||| .
